A new Phase 2 clinical study is now enrolling adults with moderate to severe asthma to evaluate the safety and efficacy of Brenipatide, an investigational, once-weekly subcutaneous injection designed ...

An asthma medication improves asthma control, respiratory quality of life, and upper airway symptoms in patients with chronic ...

Women experience more frequent asthma attacks, and prior attack history is a statistically stronger predictor of future events in men.

To inform clinicians on the best biologic agent for different populations of adults with severe asthma, 12 experts collaborated on a new clinical practice guideline published in CHEST, according to a ...

AROUND 2 MILLION PEOPLE IN THE U.S. ARE LIVING WITH SEVERE ASTHMA.WITH THE SEASON CHANGING AND DIFFERENT WEATHER PATTERNS ON ...

Robust real-world data on the effectiveness of biologic therapies in children with severe asthma remain limited, particularly ...

A landmark study has shown that severe asthma can be controlled using biologic therapies, without the addition of regular high-dose inhaled steroids which can have significant side effects. A landmark ...

—A new study from Sweden assesses the prevalence of severe asthma, highlighting the impact of the disease in this population at a time when promising new treatments are entering the market. Reviewed ...

Pregnant women with vs. without an asthma biologic prescription had a significantly lower likelihood for adverse pregnancy outcomes, according to findings published in The Journal of Allergy and ...

Recent updates on severe asthma include real-world data on triggers, efficacy of benralizumab and dupilumab, and the approval of Tezspire as add-on maintenance treatment. Read the latest updates on ...

Asthma isn’t always a quick and easy diagnosis in children. According to a 2014 task force assembled by the American Thoracic Society and the European Respiratory Society, pediatric severe asthma can ...

Not all asthma is the same. Asthma UK estimates there are 5.4 million people in the UK who live with the disease, mostly with mild to moderate forms. But at the other end of the spectrum, there are ...